Partial chromosome Y deletion
|
0.300 |
ChromosomalRearrangement
|
phenotype |
ORPHANET |
Screening for partial AZFa microdeletions in the Y chromosome of infertile men: is it of clinical relevance?
|
22537385 |
2012 |
Male sterility due to Y-chromosome deletions
|
0.300 |
ChromosomalRearrangement
|
phenotype |
ORPHANET |
Screening for partial AZFa microdeletions in the Y chromosome of infertile men: is it of clinical relevance?
|
22537385 |
2012 |
Partial chromosome Y deletion
|
0.300 |
ChromosomalRearrangement
|
phenotype |
ORPHANET |
Genetic dissection of the AZF regions of the human Y chromosome: thriller or filler for male (in)fertility?
|
20671934 |
2010 |
Male sterility due to Y-chromosome deletions
|
0.300 |
ChromosomalRearrangement
|
phenotype |
ORPHANET |
Genetic dissection of the AZF regions of the human Y chromosome: thriller or filler for male (in)fertility?
|
20671934 |
2010 |
Partial chromosome Y deletion
|
0.300 |
ChromosomalRearrangement
|
phenotype |
ORPHANET |
An azoospermic man with a de novo point mutation in the Y-chromosomal gene USP9Y.
|
10581029 |
1999 |
Male sterility due to Y-chromosome deletions
|
0.300 |
ChromosomalRearrangement
|
phenotype |
ORPHANET |
An azoospermic man with a de novo point mutation in the Y-chromosomal gene USP9Y.
|
10581029 |
1999 |
Spermatogenic Failure, Nonobstructive, Y-Linked
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Azoospermia
|
0.140 |
Biomarker
|
disease |
BEFREE |
The association of this large deletion with normal fertility shows that USP9Y, hitherto considered a candidate gene for infertility and azoospermia, does not have a key role in male reproduction.
|
19246359 |
2009 |
Azoospermia
|
0.140 |
GeneticVariation
|
disease |
LHGDN |
Study of azoospermia factor-a deletion caused by homologous recombination between the human endogenous retroviral elements and population-specific alleles in Japanese infertile males.
|
17624343 |
2008 |
Male infertility
|
0.140 |
GeneticVariation
|
phenotype |
LHGDN |
Tracking microdeletions of the AZF region in a patrilineal line of infertile men.
|
18752188 |
2008 |
Male infertility
|
0.140 |
GeneticVariation
|
phenotype |
LHGDN |
SRY and AZF gene variation in male infertility: a cytogenetic and molecular approach.
|
17762975 |
2007 |
Azoospermia
|
0.140 |
GeneticVariation
|
disease |
BEFREE |
In addition, some infrequent mutations have been identified in the ubiquitin-specific protease 9, Y-linked (USP9Y) and the synaptonemal complex protein 3 (SYCP3) gene that cause azoospermia.
|
16227348 |
2005 |
Male infertility
|
0.140 |
Biomarker
|
phenotype |
LHGDN |
[A genetic study on microdeletion of azoospermia factor region on Y chromosome of azoospermia and oligozoospermia patients].
|
15696490 |
2005 |
Male infertility
|
0.140 |
GeneticVariation
|
phenotype |
BEFREE |
Deletions in these regions remove one or more of the candidate genes (DAZ, RBMY, USP9Y, and DBY) and cause severe testiculopathy leading to male infertility.
|
11294825 |
2001 |
Azoospermia
|
0.140 |
GeneticVariation
|
disease |
BEFREE |
On the contrary, the phenotype of patients with deletion of both USP9Y and DBY seem to be invariably azoospermia with a testicular histology of Sertoli cell-only.
|
11097428 |
2000 |
Azoospermia
|
0.140 |
Biomarker
|
disease |
HPO |
|
|
|
Male infertility
|
0.140 |
Biomarker
|
phenotype |
HPO |
|
|
|
Oligospermia
|
0.130 |
GeneticVariation
|
disease |
BEFREE |
Deletions in the azoospermia factor region AZFa on the human Y chromosome and, more specifically, in the region that encompasses the ubiquitin-specific peptidase 9, Y-linked gene USP9Y have been implicated in infertility associated with oligospermia and azoospermia.
|
19246359 |
2009 |
Oligospermia
|
0.130 |
GeneticVariation
|
disease |
BEFREE |
One of these two patients had DFFRY deletion and the other had DBY deletion; their testicular phenotypes were Sertoli cell-only syndrome and hypospermatogenesis, respectively.
|
11695273 |
2001 |
Oligospermia
|
0.130 |
GeneticVariation
|
disease |
BEFREE |
While deletions or even smaller mutations in USP9Y seem to be associated with a testicular phenotype of severe hypospermatogenesis, patients with deletions of DBY may present both Sertoli cell-only syndrome and severe hypospermatogenesis.
|
11097428 |
2000 |
Oligospermia
|
0.130 |
Biomarker
|
disease |
HPO |
|
|
|
Cryptorchidism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Small testicle
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Non-obstructive azoospermia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Malignant neoplasm of prostate
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Real-time quantitative polymerase chain reaction was performed to evaluate the expression of TTTY15-USP9Y and the prostate cancer-specific antigen (PSA) level.
|
26008593 |
2015 |